SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-00-004532
Filing Date
2000-11-14
Accepted
2000-11-14 00:00:00
Documents
5
Period of Report
2000-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT w42341e10-q.htm 10-Q 275332
2 RIGHTS REVERSION AGREEMENT w42341ex10-61.txt EX-10.61 100240
3 AGREEMENT, DATED OCTOBER 24, 2000 w42341ex10-62.txt EX-10.62 74478
4 FINANCILA DATA SCHEDULE w42341ex27-01.txt EX-27.01 2060
5 FORM 10-Q w42341e10-qpdf.pdf 10-Q 311250
  Complete submission text file 0000950133-00-004532.txt   765294
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 765663
SIC: 2834 Pharmaceutical Preparations